Abstract:Recent data indicate AKI is very common among hospitalized Chinese patients and continuous renal replacement therapy (CRRT) is increasingly offered for treatment. However, only anecdotal information regarding CRRT's use in relation to other modalities and the specific manner in which it is prescribed exists currently. This report summarizes the results of a comprehensive physician survey designed to characterize contemporary dialytic management of AKI patients in China, especially with respect to the utilization of CRRT. The survey queried both nephrologists and critical care physicians across a wide spectrum of hospitals about factors influencing initial RRT modality selection, especially patient clinical characteristics and willingness to receive RRT, treatment location, and institutional capabilities. For patients initially treated with CRRT, data related to indication, timing of treatment initiation, dose, anticoagulation technique, and duration of therapy were also collected. Among AKI patients considered RRT candidates, the survey indicated 15.1% (95% CI, 12.3%-17.9%) did not actually receive dialysis at Chinese hospitals. The finding was largely attributed to prohibitively high therapy costs in the view of patients or their families. The survey confirmed the dichotomy in RRT delivery in China, occurring both in the nephrology department (with nephrologists responsible) and the intensive care unit (with critical care physicians responsible). For all patients who were offered and received RRT, the survey participants reported 63.9% (56.4%-71.3%) were treated initially with CRRT and 24.8% (19.2%-30.3%) with intermittent hemodialysis (HD) (P<0.001). The mean percentage of patients considered hemodynamically unstable at RRT initiation was 36.2% (31.3%-41.1%), although this figure was two-fold higher in patients treated initially with CRRT (43.1%; 35.8%-50.4%) in comparison to those initially treated with HD (22.4%; 16.4%-28.4%)(P<0.001). An overwhelming majority of intensive care patients were treated initially with CRRT (86.6%; 79.8-93.4%) while it was the initial modality in only 44.6% (33.5-55.7%) of patients treated in a nephrology department (P<0.001). Approximately 70% of respondents overall reported prescribing a CRRT dose in the range of 20-30 mL/kg/hr while approximately 20% of prescriptions fell above this range. Daily prescribed therapy duration demonstrated a marked divergence from values reported in the literature and standard clinical practice. Overall, the most common average prescribed value (50% of respondents) fell in the 10-20 hr range, with only 18% in the 20-24 hr range. Moreover, 32% of respondents reported an average prescribed value of less than 10 hrs per day. While the percentages for the 10-20 hrs range were essentially the same for nephrology and ICU programs, a daily duration of less than 10 hrs was much more common in nephrology programs (48.0%; 38.3%-57.9%) versus ICU programs (16%; 10.0%-24.6%)(P<0.001). Our analysis demonstrates both similarities and differences between RRT practices for AKI in China and those in the developed world. While some differences are driven by non-medical factors, future studies should explore these issues further as Chinese RRT practices are harmonized with those in the rest of the world.

SIKD is on the Road

The Role of an Integrated Care Model for Kidney Disease in the Development of Peritoneal Dialysis: A Single-Center Experience in China

Current pattern of Chinese dialysis units: a cohort study in a representative sample of units.

The History of Hemodialysis in China

Current Status of Hemodialysis Treatment in Beijing, China

Experiences with Establishing the First Self-Care Hemodialysis Program in A Hospital in Mainland China

The history of peritoneal dialysis in China: past, present and future trends

Tackling Dialysis Burden Around the World: A Global Challenge

IPDN-China promotes the development of pediatric dialysis in China

Renal replacement therapy practices for patients with acute kidney injury in China.

Clinical Research in a Modern Chinese Peritoneal Dialysis Center.

Baseline data report of the China Dialysis Outcomes and Practice Patterns Study (DOPPS)

Current Status of Maintenance Hemodialysis in Beijing, China

Efficacy and Safety of Changfu Peritoneal Dialysis Solution: a Multi-Center Prospective Randomized Controlled Trial.

WHAT PD RESEARCH IN CHINA TELLS US.

Practice of a hemodialysis alliance in the context of closed-loop hospital management

Establishing the first self-care hemodialysis training program for Two ESRD patients in mainland China

A Cross-Sectional Study Hemodialysis Patients in Shanghai Qingpu District

Serum calcium, phosphate, and iPTH levels of dialysis patients in Zhejiang Province

Analysis of the questionnaire on Kidney Disease: Improving Global Outcomes chronic kidney disease-mineral and bone disorder in Shanghai

China Collaborative Study on Dialysis: a Multi-Centers Cohort Study on Cardiovascular Diseases in Patients on Maintenance Dialysis